760987-17-5

Upstream product

• 42058-59-3 3-hydroxy-benzeneacetic acid, methyl ester 
• 106-93-4 ethylene dibromide 

Downstream Products

• 930785-39-0 tert-butyl 4-{2-[3-(2-methoxy-2-oxoethyl)phenoxy]ethyl}-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate 
• 930785-03-8 (3-{2-[(3-{[5-(6-Amino-2-butoxy-8-oxo-7,8-dihydropurin-9-ylmethyl)pyridin-2-yl]methylamino}propyl)methylamino]ethoxy}phenyl)acetic acid methyl ester 
• 930785-31-2 Methyl (3-{2-[{2-[(tert-butoxycarbonyl)(methyl)amino]ethyl}(methyl)amino]ethoxy}phenyl)acetate 
• 930785-33-4 methyl [3-(2-{4-[(tert-butoxycarbonyl)(methyl)amino]piperidin-1-yl}ethoxy)phenyl]acetate 
• 930777-73-4 2-butoxy-8-methoxy-9-{1-[3-(N-{2-[3-(methoxycarbonylmethyl)phenoxy]ethyl}-N-methylamino)propyl]piperidin-4-ylmethyl}adenine 
• 930777-96-1 2-butoxy-8-methoxy-9-(5-{4-[2-(3-methoxycarbonylmethylphenyloxy)ethyl]piperazin-1-yl}pentyl)adenine 
• 930777-72-3 2-butoxy-8-methoxy-9-(1-{2-[3-(methoxycarbonylmethyl)phenoxy]ethyl}piperidin-4-ylmethyl)adenine 
• 930777-70-1 8-methoxy-9-{1-[3-(N-{2-[3-(methoxycarbonylmethyl)phenoxy]ethyl}-N-methylamino)propyl]piperidin-4-ylmethyl}-2-(2-methoxyethoxy)adenine 
• 930777-68-7 8-methoxy-9-(1-(2-[3-(methoxycarbonylmethyl)phenoxy]ethyl)piperidin-4-ylmethyl)-2-(2-methoxyethoxy)adenine 
• 930778-31-7 C₂₁H₃₂N₂O₅ 

Relevant academic research and scientific papers

PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE

The present invention provides a compound represented by formula [I] shown below or a pharmaceutically acceptable salt thereof that has an inhibitory effect on 20-HETE producing enzyme. (in formula [I] above, the structure represented by formula [II] below: represents any of the structures represented by formula group [III] below: R1, R2, R3, and R4 independently represent a hydrogen atom, a fluorine atom, methyl, or the like, R5 represents any of the structures represented by formula group [IV]:

IMINO ETHER DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT

The compound represented by formula (I) (wherein R1 and R2 are cyclic group which may have a substituent(s) and so on.; W is a spacer of which main chain has an atom number of 1-6.; X is -O- and so on.; ringA is cyclic group which may have a substituent(s).; Y is a spacer of which main chain has an atom number of 1-6 and so on.; Z is acidic group.) a salt thereof, a solvent thereof or an N-oxide thereof or a prodrug thereof Since the compounds in the present invention have a regulatory activity for peroxisome proliferator activated receptor, the compounds in the present invention are useful as a preventive and/or therapeutic agent for diseases associating metabolic disorders (e.g., hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipidemia, atherosclerosis, hypertension, circulatory diseases, overeating, ischemic heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or a VLDL cholesterol-lowering agent and a drug for relief from risk factors of diabetes or metabolic syndrom.